One explanation may be that plasma CRP is produced principally in hepatocytes and individuals with AATD (in addition to developing emphysema) can also develop cirrhosis of the liver, potentially leading to liver failure as a result of excess deposition of abnormal α1-antitrypsin protein in the liver. The gene discussed is CRP; the disease is pulmonary emphysema.